ASX:BIT Biotron (BIT) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BIT Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.03 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield5.08%Price TargetN/A Stock AnalysisStock Analysis Get Biotron alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Biotron Stock (ASX:BIT)Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. BIT Stock News HeadlinesApril 4, 2024 | msn.comGuess which ASX healthcare stock is rocketing almost 50% on FridayFebruary 26, 2024 | bbc.co.ukBBC micro:bit playground surveyApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.February 4, 2024 | finance.yahoo.comHere's Why We're Not Too Worried About Biotron's (ASX:BIT) Cash Burn SituationDecember 17, 2023 | bbc.com'Normal' to feel a bit unwell after Covid vaccineNovember 15, 2023 | finance.yahoo.comThis Is Why We Think Biotron Limited's (ASX:BIT) CEO Might Get A Pay Rise Approved By ShareholdersOctober 21, 2023 | bbc.co.ukRegister for your free BBC micro:bits for primary schoolsSeptember 26, 2023 | msn.comIn Case You Missed It: Visual spodumene and Covid clinical trialsApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 26, 2023 | msn.comClosing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapyAugust 25, 2023 | nytimes.comThe Best Multi-Bit ScrewdriverJuly 6, 2023 | finance.yahoo.comCompanies Like Biotron (ASX:BIT) Can Afford To Invest In GrowthJune 14, 2023 | bbc.co.ukBBC micro:bit - the next genJanuary 17, 2023 | finance.yahoo.comWe're Keeping An Eye On Biotron's (ASX:BIT) Cash Burn RateSeptember 24, 2022 | ca.finance.yahoo.comBiotron Limited (BIT.AX)September 19, 2022 | reuters.comBIT.AX - Biotron Ltd | Stock Price & Latest News | ReutersJune 20, 2022 | afr.comFor two years, biotechs reigned supremeMay 7, 2022 | finance.yahoo.comIs Biotron (ASX:BIT) In A Good Position To Invest In Growth?May 2, 2022 | fool.com.auBiotron share price rockets 38% on COVID trial resultsNovember 25, 2021 | finance.yahoo.comBiotron Drug Effective Against COVID-19 In AnimalsNovember 24, 2021 | msn.comASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatmentNovember 24, 2021 | msn.comThe Biotron (ASX:BIT) share price just exploded 86% on COVID drug updateSee More Headlines Receive BIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:BIT CUSIPN/A CIKN/A Webwww.biotron.com.au Phone61 2 9805 0488FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,020,000.00 Net Margins-244.54% Pretax MarginN/A Return on Equity-103.96% Return on Assets-56.72% Debt Debt-to-Equity Ratio1.50 Current Ratio3.85 Quick Ratio2.32 Sales & Book Value Annual Sales$1.65 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow6.71 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares902,280,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.60 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesDr. Michelle Miller BSc.GCertAppFin, MSc., Ph.D., MD & Executive DirectorMr. Peter James Nightingale B.Econ (Age 67)CA, Company Secretary Comp: $120kDr. Stephen L. Becker M.D.Chief Medical OfficerKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFView All Competitors BIT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Biotron own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Enterprise Products Partners (EPD), Gemfields Group (GEM), Northern Star Resources (NST), Black Hills (BKH), BlackRock Enhanced Equity Dividend Trust (BDJ), American States Water (AWR), abrdn Global Premier Properties Fund (AWP), AllianceBernstein Global High Income Fund (AWF) and American Public Education (APEI). This page (ASX:BIT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
